FOLD - Amicus Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FOLD is currently covered by 6 analysts with an average price target of $14.47. This is a potential upside of $5.57 (62.58%) from yesterday's end of day stock price of $8.9.

Amicus Therapeutics's activity chart (see below) currently has 150 price targets and 104 ratings on display. The stock rating distribution of FOLD is 88.89% BUY and 11.11% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 47.03% with an average time for these price targets to be met of 353.17 days.

Highest price target for FOLD is $21, Lowest price target is $9, average price target is $15.

Most recent stock forecast was given by GIL BLUM from NEEDHAM on 17-Sep-2025. First documented stock forecast 19-Aug-2014.

Currently out of the existing stock ratings of FOLD, 8 are a BUY (88.89%), 1 are a HOLD (11.11%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$14

$5.33 (61.48%)

1 months 13 days ago
(17-Sep-2025)

0/1 (0%)

$5.52 (65.09%)

Buy

$12

3 months 14 days ago
(16-Jul-2025)

0/4 (0%)

$2.64 (28.21%)

Hold

$9

$0.33 (3.81%)

$14

5 months 29 days ago
(01-May-2025)

4/6 (66.67%)

$2.33 (34.93%)

165

Buy

$16

$7.33 (84.54%)

$17

8 months 3 days ago
(27-Feb-2025)

6/16 (37.5%)

$6.51 (68.60%)

454

Buy

$21

$12.33 (142.21%)

$21

9 months 16 days ago
(14-Jan-2025)

0/7 (0%)

$11.73 (126.54%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FOLD (Amicus Therapeutics) average time for price targets to be met?

On average it took 353.17 days on average for the stock forecasts to be realized with a an average price target met ratio 47.03

Which analyst has the current highest performing score on FOLD (Amicus Therapeutics) with a proven track record?

DEBJIT CHATTOPADHYAY

Which analyst has the most public recommendations on FOLD (Amicus Therapeutics)?

Debjit Chattopadhyay works at GUGGENHEIM and has 3 price targets and 2 ratings on FOLD

Which analyst is the currently most bullish on FOLD (Amicus Therapeutics)?

Michael Ulz with highest potential upside - $16.33

Which analyst is the currently most reserved on FOLD (Amicus Therapeutics)?

Jeffrey Hung with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?